These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1868824)

  • 1. The development of a seizure severity scale as an outcome measure in epilepsy.
    Baker GA; Smith DF; Dewey M; Morrow J; Crawford PM; Chadwick DW
    Epilepsy Res; 1991 Apr; 8(3):245-51. PubMed ID: 1868824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale.
    O'Donoghue MF; Duncan JS; Sander JW
    Epilepsia; 1996 Jun; 37(6):563-71. PubMed ID: 8641234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of add-on treatment with lamotrigine in partial epilepsy.
    Smith D; Baker G; Davies G; Dewey M; Chadwick DW
    Epilepsia; 1993; 34(2):312-22. PubMed ID: 8453943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parent-completed scales for measuring seizure severity and severity of side-effects of antiepileptic drugs in childhood epilepsy: development and psychometric analysis.
    Carpay HA; Arts WF; Vermeulen J; Stroink H; Brouwer OF; Peters AC; van Donselaar CA; Aldenkamp AP
    Epilepsy Res; 1996 Jul; 24(3):173-81. PubMed ID: 8832193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The determinants of seizure severity in Nigerian epileptics.
    Imam I; Talabi OA; Sanya EO; Ogunniyi A
    Niger J Clin Pract; 2005 Dec; 8(2):94-6. PubMed ID: 16477861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].
    Yamamoto T; Yamazoe T; Fujimoto A; Kobayashi R; Yokota T; Okanishi T; Uchiyama G; Ohashi T; Tanaka T; Enoki H
    Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiepileptic drugs for seizure control in people with neurocysticercosis.
    Sharma M; Singh T; Mathew A
    Cochrane Database Syst Rev; 2015 Oct; (10):CD009027. PubMed ID: 26455722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological interventions for epilepsy in people with intellectual disabilities.
    Beavis J; Kerr M; Marson AG
    Cochrane Database Syst Rev; 2007 Jul; (3):CD005399. PubMed ID: 17636795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epilepsy and the impact of an epileptology clinic for patients with mental retardation and associated disabilities in an institutional setting.
    Arain A; Shihabuddin B; Niaz F; Modur P; Taylor H; Fakhoury T; Abou-Khalil B
    Epilepsia; 2006 Dec; 47(12):2052-7. PubMed ID: 17201703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the accumulated antiepileptic drug load in chronic epilepsy reflect disease severity?
    Witt JA; Nass RD; Baumgartner T; von Wrede R; Elger CE; Surges R; Helmstaedter C
    Epilepsia; 2020 Dec; 61(12):2685-2695. PubMed ID: 33058192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinimetric approach to assessing quality of life in epilepsy.
    Cramer JA
    Epilepsia; 1993; 34 Suppl 4():S8-13. PubMed ID: 8348905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of drug adverse effects compared with seizure control for people with epilepsy: a discrete choice experiment.
    Lloyd A; McIntosh E; Price M
    Pharmacoeconomics; 2005; 23(11):1167-81. PubMed ID: 16277551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric properties of Chinese language Liverpool Seizure Severity Scale 2.0 (LSSS 2.0) and status and determinants of seizure severity for patients with epilepsy in China.
    Gao L; Xia L; Pan SQ; Xiong T; Li SC
    Epilepsy Behav; 2014 Feb; 31():187-93. PubMed ID: 24440688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring antiepileptic therapies: the patient vs the physician viewpoint.
    Chadwick D
    Neurology; 1994 Nov; 44(11 Suppl 8):S24-8. PubMed ID: 7970003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The progression of epilepsy.
    Blume WT
    Epilepsia; 2006; 47 Suppl 1():71-8. PubMed ID: 17044831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study.
    Harden CL; Herzog AG; Nikolov BG; Koppel BS; Christos PJ; Fowler K; Labar DR; Hauser WA
    Epilepsia; 2006 Sep; 47(9):1447-51. PubMed ID: 16981859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity and reliability of the Portuguese version of the Epilepsy Medication Treatment Complexity Index for Brazil.
    Ferrari CM; Castro LH; Settervall CH; de Moura RM; Coutinho PA; Oshiro IE; Alves RB; de Sousa RM
    Epilepsy Behav; 2011 Aug; 21(4):467-72. PubMed ID: 21664877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid versus slow withdrawal of antiepileptic drugs.
    Ranganathan LN; Ramaratnam S
    Cochrane Database Syst Rev; 2006 Apr; (2):CD005003. PubMed ID: 16625621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seizure severity and the quality of life.
    Smith D; Chadwick D; Baker G; Davis G; Dewey M
    Epilepsia; 1993; 34 Suppl 5():S31-5. PubMed ID: 8339714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.